Printer Friendly
The Free Library
5,677,732 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

MDS Pharma Services Announces New Vice President, Clinical Pharmacology.


KING OF PRUSSIA King of Prussia, industrialized suburban area (1990 pop. 18,406), Montgomery co., SE Pa. It has glass and steel fabricating, food processing, printing and publishing, and varied manufacturing (textiles, liquified petroleum gas, water-treatment and electrical , Pa. -- MDS MDS,
n See temporomandibular pain-dysfunction syndrome.

MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there
 Pharma Services, a leading provider of innovative drug discovery and development solutions, has appointed Vijay Vashi, Ph.D., vice president, Clinical Pharmacology. Based out of the business's Neptune, NJ, facility, he will provide clinical, scientific and operational leadership, including clinical pharmacology expertise, to client studies and interact with MDS Pharma Services operations and scientific personnel in support of Phase I clinical studies.

"Dr. Vashi brings 14 years of clinical pharmacology and drug development experience to this position. He is an excellent addition to the team," said Dr. Jerry Merritt, senior vice president and general manager, Early Clinical Research.

Prior to joining MDS Pharma Services, Vijay was employed at Purdue Pharma LLP LLP - Lower Layer Protocol , where he was senior director, Clinical Pharmacology and clinical leader of one of the company's Opioid Agonist/Antagonist Programs. He also served as associate director, Clinical Pharmacology, Central Research, Groton, Connecticut, and assistant director, Clinical Pharmacology, Clinical and Scientific Affairs for Pfizer, Inc.'s New York Office. He holds Ph.D. and M.S. degrees in Pharmacokinetics/Biopharmaceutics from the University of Tennessee The University of Tennessee (UT), sometimes called the University of Tennessee at Knoxville (UT Knoxville or UTK), is the flagship institution of the statewide land-grant University of Tennessee public university system in the American state of Tennessee.  and a B.S. (Hons.) degree from the University of London's Chelsea College (now King's College) in the United Kingdom.

Dr. Vashi has co-authored several publications and is a member of the American Society for Clinical Pharmacology and Therapeutics, the American Association of Pharmaceutical Scientists and the Rho Chi Pharmacy Honor Society.

MDS Pharma Services offers a full spectrum of resources to meet the drug discovery and development needs of the pharmaceutical and biotechnology industries. With numerous facilities strategically located around the world, the company applies advanced scientific and technological expertise to each stage of the drug discovery and development process - Early Stage: lead optimization, pre-IND research, pharmaceutical and biopharmaceutical development, early clinical research (bioequivalence bioequivalence /bio·equiv·a·lence/ (-e-kwiv´ah-lens) the relationship between two preparations of the same drug in the same dosage form that have a similar bioavailability. , phases I-IIa) and bioanalysis; and Late Stage: global clinical development (phases IIb-IV) and central lab. For more information, visit MDS Pharma Services' Web site at www.mdsps.com.

MDS Pharma Services is an integral part of MDS Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
: MDS; NYSE NYSE

See: New York Stock Exchange
: MDZ MDZ Mendez
MDZ Moskauer Deutsche Zeitung (Moscow German newspaper)
MDZ Maritime Defense Zone
MDZ Musik Der Zukunft (music label & community)
MDZ Mendoza, Mendoza, Argentina - El Plumerillo
). MDS Inc. has more than 9,000 highly skilled people in 25 countries. We provide a diverse range of superior products and services to increase our customers' speed, precision and productivity in the drug development and disease diagnosis processes. We are a global, values-driven health and life sciences company, recognized for our reliability and collaborative relationships as we help create better outcomes in the treatment of disease. Find out more at www.mdsintl.com or by calling 1-888-MDS-7222, 24 hours a day.

MDS Pharma Services (TSX:MDS) (NYSE:MDZ)
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Mar 17, 2005
Words:425
Previous Article:Gene Logic Provides Financial Guidance and Plan for Company Growth; CEO Details Potential for Drug Repositioning and Selection Business and Targets...
Next Article:SmartServ Announces Investor Update.
Topics:



Related Articles
MGI PHARMA/METHYLGENE BEGIN CLINICAL TRIAL OF MG98.
MDS Pharma Services Names John Robson Senior Director - Bioanalysis in Europe.
Clinical Site Director Named for MDS Pharma Services Facility in Phoenix.
MDS Pharma Services Introduces Monoclonal Antibody Development Program.
MDS Pharma Services Introduces Updated Pharmacology Services Component of Internet-Based Data Delivery Platform.
MDS Pharma Services Appoints Senior Vice President, Discovery and Preclinical.
Cardiovascular Safety Assessment a Top Priority for MDS Pharma Services.
DYNOGEN ACQUIRES EXCLUSIVE RIGHTS TO PUMOSETRAG.
MDS Pharma Services Expands Early Clinical Research Capacity to More Than 1,000 Beds.
MDS Pharma Services Takes Action to Enhance Performance and Profitability.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles